- Disease-modifying
antirheumatic drugs (DMARDs)
comprise a
category of
otherwise unrelated disease-modifying
drugs defined by
their use in
rheumatoid arthritis...
-
Psoriatic arthritis (PsA) is a long-term
inflammatory arthritis that
occurs in
people affected by the
autoimmune disease psoriasis. The
classic features...
- name
Arava among others, is an
immunosuppressive disease-modifying
antirheumatic drug (DMARD), used in
active moderate-to-severe
rheumatoid arthritis...
-
inadequately to, or who are
intolerant to one or more disease-modifying
antirheumatic drugs (DMARDs).
Upadacitinib may be used as
monotherapy or in combination...
- ATC code M01 Anti-inflammatory and
antirheumatic products is a
therapeutic subgroup of the
Anatomical Therapeutic Chemical classification System, a system...
-
NSAIDs are
frequently used to help with symptoms. Disease-modifying
antirheumatic drugs (DMARDs), such as
hydroxychloroquine and methotrexate, may be...
- sold
under the
brand name
Humira and others, is a disease-modifying
antirheumatic drug and
monoclonal antibody used to
treat rheumatoid arthritis, juvenile...
-
treatment for life-threatening
autoimmune diseases where disease-modifying
antirheumatic drugs (DMARDs) have been ineffective. For example,
systemic lupus erythematosus...
- side effects, TNF
blockers are used.
Traditional disease-modifying
antirheumatic drugs (DMARDs) are not used for
people without peripheral disease signs...
- to be safe for the baby.
Sulfasalazine is in the disease-modifying
antirheumatic drugs (DMARDs)
family of medications. It is
unclear exactly how it works...
